Pharmacopeia
CWP-0031
AZITHROMYCIN
Anti-infectives · Anti-infectives · Level 3
Core pharmacology
- Class Group
ANTIBIOTIC:
MACROLIDE- Legacy Cicm Level
Level 3
- Presentation
PO, IV
- Mechanism of action
Inhibits 50s subunit to prevent protein synthesis
Bacteriocidal/static- Antimicrobial Spectrum
1.Gram positives
2. Anaerobes
3. Obligate intracellular organisms (legionella, mycoplasma)
4. Gram negatives including Moraxella, Neisseria, H. Influenzae- Adverse Effects Toxicity
1. Nausea, vomiting, diarrhea
2. Hypersensitivity
3. Less QT prolongation
4. Inhibits CYP3A4 (increased warfarin, carbamazepine, ciclosporin, valproate, tacrolimus, digoxin)
Inhibits P-glycoprotein- Absorption
37% oral absorption
- Distribution
Poor CSF penetration but good lung penetration
- Protein binding
12-50% PB
- Volume of distribution
Vd 0.5L/kg
- Metabolism
Hepatic metabolism to inactive metabolites
- Excretion
Major route of excretion is bile
12% unchanged in the urine- Half-life
T1/2 of 68 hours